EU citizens have the right to access healthcare in any EU country and to be reimbursed for care abroad by their home country. Directive 2011/24/EU on patients’ rights in cross-border healthcare sets out the conditions under which a patient may travel to another EU country to receive medical care and reimbursement. It covers healthcare costs, as well as the prescription and delivery of medications and medical devices. Key elementsWith health policies and systems increasingly interconnected, the Directive makes it easier to access:
The provisions strike the right balance between maintaining the sustainability of health systems, while protecting patients' right to seek treatment outside their home country. The Directive:
|
Patients will be represented in the network by Representative of patients’ organisations. The representative of patients’ organisations act as a full member of the board of the network in order to:
|
The Patients Subcommittee is composed by a selection of representatives from different patients’ organisations. It is coordinated by one member of the EOC in order to ensure consistency in the development of the Network. One of the members shall be appointed as the chairperson by the rest of the Subcommittee for a period of two years.
All patients´organisations are invited to participate and become members of the Patients Subcommittee. Patients´organisations shall inform the coordinating centre in writing the name and contact details of two representatives in order to ensure the attendance of at least one representative to the meetings. Only officially nominated representatives are allowed to attend and participate in meetings. |
As a result of the paediatric transplantation network activities, will strive to increase life expectancy and quality of life of paediatric patients requiring a solid organ or hematopoietic progenitor transplantation and their families, and will provide added value in patients/families/patients’ organizations, by:
|